Skip to main content

Table 1 Outcomes of Therapeutic efficacy studies (TES) of artemether-lumefantrine in P. falciparum cases

From: Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal

Districts/study year

Kailali

Kanchanpur

Jhapa

Total

2013

2014

2013

2014

2013

2014

TES outcomes

 Total P. falciparum Screened

46

22

9

5

13

11

106

 TES enrollment cases

13

6

7

1

1

0

28

 Lost to follow up/Drop out

3

0

0

0

1

0

4

 TES completed

10

6

7

1

0

0

24

Adequate Clinical and Parasitological Response (ACPR)

9

6

7

1

  

23

 Early Treatment Failure (ETF)

0

0

0

0

  

0

 Late Treatment Failure (LTF)

1

0

0

0

  

1

  1. Note: None of the patients who were followed up for 28 days developed any adverse events. Of the 24, five patients were afebrile in day 3 and 19 became afebrile on day 2. Out of 24 patients, 21 had cleared parasitemia on day 3 and three cleared parasitemia on day 7 and one remained parasitemic until 14 days